Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Brenner

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
Experimental Neurology|October 10, 2020
Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43<sup>G298S</sup> transgenic miceKirsten Sieverding, Johannes Ulmer, Clara Bruno, et al.
Cell Death & Disease|August 3, 2024
Heterozygous knockout of Synaptotagmin13 phenocopies ALS features and TP53 activation in human motor neuronsJohannes Lehmann, Amr Aly, Christina Steffke, et al.
Neurobiology of Aging|May 10, 2022
Methylome analysis of ALS patients and presymptomatic mutation carriers in blood cellsWolfgang P Ruf, Eilis Hannon, Axel Freischmidt, et al.
Acta Neuropathologica|October 7, 2014
Inflammatory dysregulation of blood monocytes in Parkinson's disease patientsVeselin Grozdanov, Corinna Bliederhaeuser, Wolfgang P Ruf, et al.
Gastroenterology|August 25, 2015
Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin StudyRohit Loomba, Nicholas Schork, Chi-Hua Chen, et al.
Current Pathobiology Reports|May 31, 2016
The role of IL-17 signaling in regulation of the liver-brain axis and intestinal permeability in Alcoholic Liver DiseaseHsiao-Yen Ma, Jun Xu, Xiao Liu, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 14, 2013
Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel diseasePhilippa C Lavallée, Julien Labreuche, Dorothée Faille, et al.
Ebiomedicine|September 20, 2025
Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using an in-house assay for the detection of neurofilament medium chainBadrieh Fazeli, Sara Botzenhardt, Franziska Bachhuber, et al.
Neurology. Genetics|October 27, 2025
Neurofilament Light Chain as a Biomarker of Disease Progression in Lafora DiseaseLorenzo Muccioli, Bazile Ganceviciute, Felicitas Becker, et al.
Neurological Research and Practice|June 27, 2020
Genotypes and phenotypes of patients with Lafora disease living in GermanyDavid Brenner, Tobias Baumgartner, Sarah von Spiczak, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Experimental Neurology|October 10, 2020
Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43<sup>G298S</sup> transgenic miceKirsten Sieverding, Johannes Ulmer, Clara Bruno, et al.
Cell Death & Disease|August 3, 2024
Heterozygous knockout of Synaptotagmin13 phenocopies ALS features and TP53 activation in human motor neuronsJohannes Lehmann, Amr Aly, Christina Steffke, et al.
Neurobiology of Aging|May 10, 2022
Methylome analysis of ALS patients and presymptomatic mutation carriers in blood cellsWolfgang P Ruf, Eilis Hannon, Axel Freischmidt, et al.
Acta Neuropathologica|October 7, 2014
Inflammatory dysregulation of blood monocytes in Parkinson's disease patientsVeselin Grozdanov, Corinna Bliederhaeuser, Wolfgang P Ruf, et al.
Gastroenterology|August 25, 2015
Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin StudyRohit Loomba, Nicholas Schork, Chi-Hua Chen, et al.
Current Pathobiology Reports|May 31, 2016
The role of IL-17 signaling in regulation of the liver-brain axis and intestinal permeability in Alcoholic Liver DiseaseHsiao-Yen Ma, Jun Xu, Xiao Liu, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 14, 2013
Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel diseasePhilippa C Lavallée, Julien Labreuche, Dorothée Faille, et al.
Ebiomedicine|September 20, 2025
Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using an in-house assay for the detection of neurofilament medium chainBadrieh Fazeli, Sara Botzenhardt, Franziska Bachhuber, et al.
Neurology. Genetics|October 27, 2025
Neurofilament Light Chain as a Biomarker of Disease Progression in Lafora DiseaseLorenzo Muccioli, Bazile Ganceviciute, Felicitas Becker, et al.
Neurological Research and Practice|June 27, 2020
Genotypes and phenotypes of patients with Lafora disease living in GermanyDavid Brenner, Tobias Baumgartner, Sarah von Spiczak, et al.
Pageof 13